Search CORE

2 research outputs found

The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia

Author: A Carobbio
C Besses
C Besses
C Langer
CL Balduini
CN Harrison
CR Rinaldi
D Lekovic
E Ejerblad
E Gillespie
EC Storen
G Birgegard
G Birgegard
G Birgegard
G Finazzi
G Finazzi
G Tortorella
G Tortorella
Gunnar Birgegård
H Gisslinger
HL Geyer
IE Ahn
J Palmblad
J Rey
J Samuelsson
J Schwarz
J Thiele
JD Erusalimsky
L Gugliotta
L Gugliotta
L Gugliotta
LI Kornblihtt
M Ahluwalia
M Ahluwalia
M Hultdin
M Merup
M Steurer
MG Mazzucconi
MG Mazzucconi
MN Silverstein
N Cascavilla
PE Petrides
PJ Campbell
PJ Genderen VAN
R Scherber
RM Petitt
S Cortelazzo
S Sacchi
S Schmitz
SM Fruchtman
T Barbui
T Barbui
T Barbui
T Barbui
U Budde
W Abe Andes
Y Hong
Y Hong
YR Espasandin
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia

Author: A Tefferi
A Tomer
C Besses
Chiaki Nakaseko
CN Harrison
E Rumi
EM Mazur
F Passamonti
G Birgegård
H Gisslinger
Heinrich Achenbach
Hiroki Yamaguchi
Jingyang Wu
JJ Kiladjian
K Dan
L Falchi
L Gugliotta
LA Solberg Jr
Michiaki Koike
R Frewin
SH Swerdlow
Shinichiro Okamoto
T Barbui
T Shimomura
Takaaki Chou
William Vainchenker
Y Hong
Y Kanakura
YR Espasandin
Yukari Shirasugi
Yuzuru Kanakura
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

core

core